Patent portfolio

Biomarker and diagnostics portfolio

1. Prognostic and Diagnostic Glycan-based Biomarkers of Brain Damage

• European patent No. 3283880
  US patent No. 10,739,335
  Canadian patent No. 2,982,503
  Israeli patent No. 254 980
  
  

2. Non-invasive Brain Injury Diagnostic Device

• PCT application WO/2018/154,401, has entered into national phases
  South African patent (number pending)
  Utility model granted in China and Australia

3. Device and Method for Detecting of Brain injury in a Subject

• PCT application WO 2021/099677
  Australian patent No. 2020104474
• Finnish Utility model No. 1317
  
  

4. A Method for Determining a Lectin-binding Glycan Indicative To Traumatic Brain Injury

• PCT application WO 2021/205059
  
  

5. A Method for Diagnosis of Traumatic Brain Injury

• PCT-application PCT/FI2023/050076
  

6. Method of Detecting Tissue Damage

• PCT-application PCT/FI2022/050805
  

7. A Hand-held Liquid Sample Collection and Testing Device

• Finnish utility model No. 13331
• German and Austrian utility models pending
  

Drug development portfolio

1. Multivalent Compounds for Use in the Treatment and Prevention of Brain Damage

• US patent No. 9,975,846
  Finnish patent No. 127024
  Israeli patent No. 251407
  European patent No. 3201173

2. Conjugates and Conjugates for Use in Preventing or Treating of Brain Damage and Neurodegenerative Diseases

• PCT application WO 2021/038125

Other patents 

1. Method for Determining Coronavirus and Kit for the Same

• PCT application WO 2021/205058